Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Bifidobacterium animalis subsp. lactis LAFTI B94 and Reduced Gastrointestinal Symptoms

Research synthesisLow evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 review-level studies, all reported beneficial effects on gastrointestinal symptoms, with effect sizes ranging from small to moderate (predominantly moderate). The most detailed evidence comes from a systematic review of 513 athletes and recreationally active adults. No statistically significant findings were reported, and no specific dose or form data were extracted.

  • Studied populations: Athletes and recreationally active adults

Caveats: Evidence base is small (only 3 studies) and all are review-level, not randomized controlled trials — conclusions should be considered preliminary. No studies reported statistically significant results, so the effect may be smaller than the predominant direction suggests. Available evidence is overwhelmingly positive, but publication bias is a concern (null-result studies may be unpublished or unindexed).

Generated Jun 11, 2026
3 of 3 papers
Back to top